Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes
Objective Insulin-dependent diabetes can occur with immune checkpoint inhibitor (ICI) therapy. We aimed to characterize the frequency, natural history and potential predictors of ICI-induced diabetes.Research design and methods We reviewed 1444 patients treated with ICIs over 6 years at our cancer c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/7/1/e000591.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|